UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 180

Sortiert nach

Author's reply: "Staging the pre-procedural prophylaxis in decompensated cirrhosis"

Digestive and liver disease, 2022-08, Vol.54 (8), p.1133-1134

2022

Link zum Volltext

Verfügbarkeit prüfen

Direct oral anticoagulants for portal vein thrombosis in cirrhosis: Good news from meta-analysis?

Digestive and liver disease, 2022-01, Vol.54 (1), p.54-55

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypercoagulability in cirrhosis: causes and consequences

Journal of thrombosis and haemostasis, 2011-09, Vol.9 (9), p.1713-1723

2011

Link zum Volltext

Verfügbarkeit prüfen

Implementing pre-procedural thrombopoietin receptor agonists in cirrhotic patients with severe thrombocytopenia: Indiscriminate, selective or unneeded?

Digestive and liver disease, 2021-11, Vol.53 (11), p.1394-1395

2021

Link zum Volltext

Verfügbarkeit prüfen

Thrombopoietin receptor agonists before elective invasive procedures in cirrhotic patients with thrombocytopenia: ready to start?

Digestive and liver disease, 2021-10, Vol.53 (10), p.1364-1365

2021

Link zum Volltext

Verfügbarkeit prüfen

Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)

Digestive and liver disease, 2022-11, Vol.54 (11), p.1520-1526

2022

Link zum Volltext

Verfügbarkeit prüfen

Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy: comment

Journal of thrombosis and haemostasis, 2015-10, Vol.13 (10), p.1941-1943

2015

Link zum Volltext

Verfügbarkeit prüfen

Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis

Journal of viral hepatitis, 2014-02, Vol.21 (2), p.90-98

2014

Link zum Volltext

Verfügbarkeit prüfen

Inherited prothrombotic risk factors in children with extrahepatic portal vein obstruction: a case-control study

Journal of hepatology, 2017, Vol.66 (1), p.S180-S180

2017

Link zum Volltext

Verfügbarkeit prüfen

Inherited prothrombotic risk factors in children with extrahepatic portal vein obstruction(EHPVO). A case–control study

Digestive and liver disease, 2017-02, Vol.49 (1), p.e30-e30

2017

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and monitoring of portal hypertension

Digestive and liver disease, 2008-05, Vol.40 (5), p.312-317

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of von Willebrand factor/ADAMTS-13 on the pro-coagulant imbalance detected in cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S584-S585

2017

Link zum Volltext

Verfügbarkeit prüfen

Validation of the Baveno VI criteria for screening of esophageal varices in patients with metabolic and alcohol related compensated advanced chronic liver disease

Digestive and liver disease, 2017-02, Vol.49 (1), p.e29-e29

2017

Link zum Volltext

Verfügbarkeit prüfen

P0166 : Anticoagulation does not increase portal hypertension related bleeding, but exposes patients with cirrhosis to a high risk of minor hemorrhages. Results from a comparative cohort study

Journal of hepatology, 2015-04, Vol.62, p.S365-S365

2015

Link zum Volltext

Verfügbarkeit prüfen

P464 RESISTANCE TO THROMBOMODULIN IS ASSOCIATED WITH DE NOVO PORTAL VEIN THROMBOSIS AND COULD BE A MODIFIABLE FACTOR TO IMPROVE PROGNOSIS IN PATIENTS WITH CIRRHOSIS

Journal of hepatology, 2014-04, Vol.60 (1), p.S223-S224

2014

Link zum Volltext

Verfügbarkeit prüfen

Increased Plasma Levels of Von Willebrand Factor and Factor VIII (FVIII) During Acute Bacterial Infection Drive a Pro-Hemostatic Imbalance and Herald Severe Outcome in Cirrhosis

Journal of hepatology, 2016, Vol.64 (2), p.S290-S291

2016

Link zum Volltext

Verfügbarkeit prüfen

Screening of oesophagogastric varices in virus-related compensated advanced chronic liver disease: Beyond the Baveno VI criteria

Digestive and liver disease, 2017-02, Vol.49 (1), p.e38-e38

2017

Link zum Volltext

Verfügbarkeit prüfen

P1059 PORTAL HYPERTENSION BUT NOT HCC RISK IS ATTENUATED IN COMPENSATED CIRRHOTICS FOLLOWING 10 YEARS OF TREATMENT WITH NUCLEOS(T)IDE ANALOGS

Journal of hepatology, 2014-04, Vol.60 (1), p.S429-S430

2014

Link zum Volltext

Verfügbarkeit prüfen

259 DETERMINANTS OF BLEEDING FROM ESOPHAGEAL VARICES IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB

Journal of hepatology, 2013-04, Vol.58, p.S110-S110

2013

Link zum Volltext

Verfügbarkeit prüfen

Screening and surveillance of esophageal varices: Validation of Baveno VI criteria in a cohort of cirrhotic HCV patients

Digestive and liver disease, 2016-02, Vol.48, p.e17-e17

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of von Willebrand factor and ADAMTS-13 on the pro-coagulant imbalance of patients with cirrhosis

Digestive and liver disease, 2017-02, Vol.49 (1), p.e34-e34

2017

Link zum Volltext

Verfügbarkeit prüfen

P0206 : Prevention of bleeding following invasive procedures in cirrhotic patients: A single center experience

Journal of hepatology, 2015-04, Vol.62, p.S383-S383

2015

Link zum Volltext

Verfügbarkeit prüfen

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma

Journal of viral hepatitis, 2007-02, Vol.14 (2), p.133-139

2007

Link zum Volltext

Verfügbarkeit prüfen

P0157 : Adherence and safety of beta-blockers in elderly patients with cirrhosis and portal hypertension: A multi-center cross-sectional study

Journal of hepatology, 2015-04, Vol.62, p.S361-S361

2015

Link zum Volltext

Verfügbarkeit prüfen

More on: enhanced thrombin generation in patients with cirrhosis‐induced coagulopathy

Journal of thrombosis and haemostasis, 2011-03, Vol.9 (3), p.612-613

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 180

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(154)

Publikationsform

Artikel
(180)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(81)
Science & Technology
(69)
Life Sciences & Biomedicine
(68)
Female
(47)
Male
(45)
Gastroenterology & Hepatology
(38)
Gastroenterology And Hepatology
(37)
Middle Aged
(36)
Adult
(34)
Biological And Medical Sciences
(30)
Medical Sciences
(28)
Aged
(27)
Liver Cirrhosis - Complications
(26)
Gastroenterology. Liver. Pancreas. Abdomen
(15)
Risk Factors
(13)
Adolescent
(12)
Hematology
(12)
Other Diseases. Semiology
(12)
Liver. Biliary Tract. Portal Circulation. Exocrine Pancreas
(11)
Case-Control Studies
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Author's reply: "Staging the pre-procedural prophylaxis in decompensated cirrhosis"

Direct oral anticoagulants for portal vein thrombosis in cirrhosis: Good news from meta-analysis?

Hypercoagulability in cirrhosis: causes and consequences

Implementing pre-procedural thrombopoietin receptor agonists in cirrhotic patients with severe thrombocytopenia: Indiscriminate, selective or unneeded?

Thrombopoietin receptor agonists before elective invasive procedures in cirrhotic patients with thrombocytopenia: ready to start?

Preprocedural prophylaxis with blood products in patients with cirrhosis: Results from a survey of the Italian Association for the Study of the Liver (AISF)

Fresh frozen plasma transfusion fails to influence the hemostatic balance in critically ill patients with a coagulopathy: comment

Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis

Inherited prothrombotic risk factors in children with extrahepatic portal vein obstruction: a case-control study

Inherited prothrombotic risk factors in children with extrahepatic portal vein obstruction(EHPVO). A case–control study

Diagnosis and monitoring of portal hypertension

Impact of von Willebrand factor/ADAMTS-13 on the pro-coagulant imbalance detected in cirrhosis

Validation of the Baveno VI criteria for screening of esophageal varices in patients with metabolic and alcohol related compensated advanced chronic liver disease

P0166 : Anticoagulation does not increase portal hypertension related bleeding, but exposes patients with cirrhosis to a high risk of minor hemorrhages. Results from a comparative cohort study

P464 RESISTANCE TO THROMBOMODULIN IS ASSOCIATED WITH DE NOVO PORTAL VEIN THROMBOSIS AND COULD BE A MODIFIABLE FACTOR TO IMPROVE PROGNOSIS IN PATIENTS WITH CIRRHOSIS

Increased Plasma Levels of Von Willebrand Factor and Factor VIII (FVIII) During Acute Bacterial Infection Drive a Pro-Hemostatic Imbalance and Herald Severe Outcome in Cirrhosis

Screening of oesophagogastric varices in virus-related compensated advanced chronic liver disease: Beyond the Baveno VI criteria

P1059 PORTAL HYPERTENSION BUT NOT HCC RISK IS ATTENUATED IN COMPENSATED CIRRHOTICS FOLLOWING 10 YEARS OF TREATMENT WITH NUCLEOS(T)IDE ANALOGS

259 DETERMINANTS OF BLEEDING FROM ESOPHAGEAL VARICES IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA TREATED WITH SORAFENIB

Screening and surveillance of esophageal varices: Validation of Baveno VI criteria in a cohort of cirrhotic HCV patients

Impact of von Willebrand factor and ADAMTS-13 on the pro-coagulant imbalance of patients with cirrhosis

P0206 : Prevention of bleeding following invasive procedures in cirrhotic patients: A single center experience

Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma

P0157 : Adherence and safety of beta-blockers in elderly patients with cirrhosis and portal hypertension: A multi-center cross-sectional study

More on: enhanced thrombin generation in patients with cirrhosis‐induced coagulopathy

Suchergebnisse filtern